Matthew Chorney, MD
Adult Reconstructive Orthopaedic Surgery · Easton, PANPI 1114451192
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,575 of the $11,623 with a category attached, or 65.2%. 15 manufacturers reported payments, led by Smith+Nephew at 54.8% of the total. Reporting peaked in 2023 at $5,010 and has fallen 86.9% since, to $655 in 2025.
Across 57 payments — averaging $203.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$6K
- Stryker$2K
- Novus Surgical Solutions LLC$1K
- Johnson & Johnson$566
- Omnilife Science, Inc$556
- Zimmer Biomet$265
- plus $689 from 9 others
What the payments were for
- Travel & lodging$3073%
- Food & beverage$3,74132%
- Education$7,57565%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 2 | $6,375 |
| Stryker | 26 | $1,845 |
| Novus Surgical Solutions LLC | 3 | $1,327 |
| Johnson & Johnson | 5 | $566 |
| Omnilife Science, Inc | 5 | $556 |
| Zimmer Biomet | 6 | $265 |
| Innovation Technologies Inc | 1 | $156 |
| Acumed LLC | 1 | $142 |
| Illuminoss Medical, Inc. | 1 | $102 |
| Medical Device Business Services, Inc. | 2 | $85 |
| Conformis, Inc. | 1 | $48 |
| Electronic Waveform Lab, Inc. | 1 | $44 |
| KCI USA, Inc. | 1 | $41 |
| Novus Surgical Consultants | 1 | $38 |
| AbbVie | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,623 in reported general payments places this provider in the 70th percentile of 51 adult reconstructive orthopaedic surgery providers in Pennsylvania.
See all adult reconstructive orthopaedic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 19 | $910 |
| Diclofenac Sodium | 16 | $294 |
| Meloxicam | 45 | $89 |
| Amoxicillin | 13 | $28 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Easton
- Robert BoothPhiladelphia$15M
- Javad ParviziPhiladelphia$2.8M
- Thomas MeadeBethlehem$411K
- Kevin AnbariAllentown$344K
- Christopher MelnicPhiladelphia$307K
- Frank Johannes PlatePittsburgh$239K
- Gary UpdegroveHershey$119K
- Jonathon BrownAllentown$89K
- Jeffrey SeweckePittsburgh$84K
- Jeremy GebhartMeadville$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.